DEUTSCHE BANK AG\ - AQUESTIVE THERAPEUTICS INC ownership

AQUESTIVE THERAPEUTICS INC's ticker is AQST and the CUSIP is 03843E104. A total of 66 filers reported holding AQUESTIVE THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 2.09 and the average weighting 1.4%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of AQUESTIVE THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$0
-100.0%
21
-98.5%
0.00%
Q2 2021$6,000
-91.8%
1,398
-90.1%
0.00%
Q1 2021$73,000
-27.7%
14,132
-25.3%
0.00%
Q4 2020$101,000
-81.1%
18,917
-82.8%
0.00%
Q3 2020$535,000
+970.0%
110,277
+963.5%
0.00%
Q2 2020$50,000
+233.3%
10,369
+162.0%
0.00%
Q2 2019$15,000
-82.1%
3,957
-68.1%
0.00%
Q1 2019$84,000
+211.1%
12,391
+176.8%
0.00%
Q4 2018$27,000
-93.1%
4,477
-79.9%
0.00%
Q3 2018$389,00022,3260.00%
Other shareholders
AQUESTIVE THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Bratton Capital Management, L.P. 11,503,294$55,848,00077.67%
Bracebridge Capital, LLC 428,571$2,083,0000.33%
Oak Grove Capital LLC 89,000$432,0000.20%
Perceptive Advisors 1,750,000$8,496,0000.12%
Virtu Financial LLC 117,206$569,0000.10%
WEDBUSH SECURITIES INC 103,240$501,0000.05%
J. Goldman & Co LP 117,600$571,0000.04%
Engineers Gate Manager LP 68,300$332,0000.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 118,900$577,0000.01%
Brandywine Global Investment Management, LLC 137,029$666,0000.01%
View complete list of AQUESTIVE THERAPEUTICS INC shareholders